We have some exciting news: Swiss HLG would like to extend a warm welcome to our new co-opted board member Nathalie Jenni. With her close to 20 years of combined valuable experience and expertise as both in-house counsel and external independent attorney, Nathalie will bring new insights, ideas and opportunities to Swiss HLG and our members. We eagerly look forward to her input and contribution to our association.
Initiating her career at a commercial law firm in Basel, Switzerland, with her primary area of practice being contractual law and the pharmaceutical industry, Nathalie then moved to the biopharma industry where she spent 15 years as an in-house counsel. For over 12 years, Nathalie complemented business development teams, as the responsible signatory for legal matters as well as being a co-shaping and co-deciding part of the negotiation team for strategic and business relevant deals. Becoming independent at the end of 2021, she founded her own company in 2022.
Nathalie is a Swiss attorney and currently acts as a legal consultant and attorney for start-ups and SMEs in the biopharma field. She’s specialized on matters related to preclinical development and business development, with core expertise in and passion for complex licensing, collaboration and co-development agreements as well as option deals for compounds, cell therapies and vaccines.
Nathalie comments ¨I am delighted to join the Swiss HLG and help to foster a vibrant community of dealmakers in Switzerland, committed to enabling fair, balanced and beneficial deals¨.